oxidopamine has been researched along with Nicotine Addiction in 1 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rezvani, AH | 1 |
| Eddins, D | 1 |
| Slade, S | 1 |
| Hampton, DS | 1 |
| Christopher, NC | 1 |
| Petro, A | 1 |
| Horton, K | 1 |
| Johnson, M | 1 |
| Levin, ED | 1 |
1 other study available for oxidopamine and Nicotine Addiction
| Article | Year |
|---|---|
Neonatal 6-hydroxydopamine lesions of the frontal cortex in rats: persisting effects on locomotor activity, learning and nicotine self-administration.
Topics: Animals; Animals, Newborn; Brain Chemistry; Chromatography, High Pressure Liquid; Dopamine; Female; | 2008 |